Short answer
Insulet Corporation (PODD) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q3 fiscal 2026 results for the quarter ended September 30, 2026.
Insulet Corporation 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 fiscal 2026 results for the quarter ended September 30, 2026
- Full financial results and management commentary available in Exhibit 99.1
- Results announcement dated November 4, 2026
Item 7.01 · Regulation FD Disclosure
- $1 billion share repurchase authorization through December 31, 2028
- Approximately $400 million targeted for fourth-quarter 2026 repurchases using existing cash
- Capital return signals management confidence while reducing cash available for other investments
- Flexible execution through open-market, private transactions, accelerated repurchases or Rule 10b5-1 plans
- Additional authorization, separate from prior programs, but no obligation to complete purchases
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $842.0M, up 19.2%, slightly above constant-currency guidance ceiling
- Omnipod revenue $836.6M, up 19.7%, led by international growth of 31.7%
- Operating margin 22.5%, up 590 basis points, with net income $141.1M versus $87.6M
- FY2026 total growth guidance raised to 21%-22%, with adjusted operating margin expansion now approximately 150 basis points
- $1B share repurchase authorized, including approximately $400M planned in Q4 using existing cash
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Insulet Corporation 8-K filings
Get the next PODD 8-K as it lands
Follow PODD for push alerts, or ask the research agent what this filing means.